IBIO – ibio, inc. (US:NASDAQ)
Stock Stats
News
12/19
05:58 am
ibio
Medium
iBio (NASDAQ:IBIO) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
12/16
04:37 pm
ibio
Medium
iBio (NASDAQ:IBIO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
11/24
04:15 pm
ibio
Medium
iBio to Participate in the 8th Annual Evercore Healthcare Conference
11/16
01:09 am
ibio
Medium
iBio (NASDAQ:IBIO) was upgraded by analysts at Wall Street Zen from
11/12
04:27 pm
ibio
Medium
iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update [Yahoo! Finance]
10/29
07:02 pm
Reiterates
Outperform
Outperform
Oppenheimer Holdings, Inc.
0.0%
10/21
08:03 am
Initiates
Outperform
Oppenheimer Holdings, Inc.
Low
0.9%
10/21
05:39 am
Initiates
Outperform
Oppenheimer
Medium
3.7%
10/21
05:39 am
Initiates
Outperform
Oppenheimer
Medium
3.7%
10/20
04:34 pm
Initiates
OUTPERFORM
OPPENHEIMER
High
16.3%
12/19
04:45 pm
ibio
Medium
Form SCHEDULE 13G iBio, Inc. Filed by: Logos Global Management LP
12/17
05:42 pm
ibio
Neutral
Form SCHEDULE 13G iBio, Inc. Filed by: EcoR1 Capital, LLC
12/16
04:40 pm
ibio
Medium
Form SCHEDULE 13G iBio, Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
12/3
03:19 pm
ibio
Low
Form SCHEDULE 13G/A iBio, Inc. Filed by: Affinity Asset Advisors, LLC
11/24
04:10 pm
ibio
Medium
Form 4 iBio, Inc. For: Nov 20 Filed by: Schimmelpennink Evert B.
Show more
Top News Gainers
12/2 iBio to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference 41.4%
2/3 iBio and CC-Pharming Initiate Joint Development of Coronavirus Vaccine 39.6%
2/28 Form S-3 iBio, Inc. 28.9%
8/19 iBio Inks 3D Bioprinting Agreement 28.6%
3/18 iBio Announces Development of Proprietary COVID-19 Vaccine Candidates 12.2%
8/26 iBio and CC-Pharming Expand Business Collaboration in China 10.5%
3/12 iBio Announces Leadership Succession, Appoints Thomas F. Isett Co-Chairman & CEO 9.6%
2/25 Form 8-K/A iBio, Inc. For: Feb 20 9.5%
3/23 Form 4 iBio, Inc. For: Mar 17 Filed by: Isett Thomas Francis 3rd 6.9%
4/27 iBio Estimates ~500 Million Dose Capacity for COVID-19 Vaccine from its FastPharming Facility™ 6.7%
Top News Decliners
10/25 iBio, Inc. Prices $5,000,000 Public Offering -51.2%
3/2 Form DEFA14A iBio, Inc. -30.9%
10/24 Form S-1/A iBio, Inc. -27.4%
3/2 Thinking about buying stock in Aurora Cannabis, Chesapeake Energy Corp, FuelCell Energy, iBio, or Pinterest? -23.8%
3/9 Form 8-K iBio, Inc. For: Mar 05 -22.3%
8/20 Thinking about buying stock in Apache, CNH Industrial, Home Depot, Ibio, or Vivus? -20.4%
1/13 Form PRE 14A iBio, Inc. For: Feb 10 -18.2%
10/28 Form 8-K iBio, Inc. For: Oct 25 -16.5%
3/18 Form 8-K iBio, Inc. For: Mar 18 -15.4%
4/9 iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute -15.0%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3